The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission is to mentor and educate clinician investigators in the field of hepatology.
The activities of the Advanced Liver Diseases Study Group span from population-based research that utilizes the extensive resources of the Rochester Epidemiology Project to vascular endothelial pathophysiology. Additional research areas include the development of novel diagnostic tools, the conduct of therapeutic clinical trials, and health services research including economic analysis and health-related quality of life assessment.
The group is part of the Hepatic Vascular Biology and Function Lab and Hepatocellular Carcinoma Lab programs as a major initiative involves collaboration with scientists to establish translational research.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.